	US 7,579,003 B2
	HBsAg-BCG combined vaccine for intracutaneous injection and preparation method thereof
Lijie Jin, Changchun (China); Zhi Wang, Changchun (China); Xiaolin Zhao, Changchun (China); Lihua Yang, Changchun (China); Wange Chen, Changchun (China); Aidong Yu, Changchun (China); Junye Sun, Changchun (China); Fuxue Zou, Changchun (China); Yanming Liu, Changchun (China); Aihong Liu, Changchun (China); Lihong Yu, Changchun (China); Yan Cai, Changchun (China); Manlun Yu, Changchun (China); Yuwu Wang, Changchun (China); Changjun Zhou, Changchun (China); Tong Yang, Changchun (China); Dejuan Li, Changchun (China); Xuan Luo, Changchun (China); and Li Li, Changchun (China)
Assigned to Changchun Institute of Biological Products, Jihn Province (China)
Appl. No. 10/559,471 PCT Filed May 26, 2004, PCT No. PCT/CN2004/000534 § 371(c)(1), (2), (4) Date May 22, 2006, PCT Pub. No. WO2004/108156, PCT Pub. Date Dec. 16, 2004.
Claims priority of application No. 03 1 27065 (CN), filed on Jun. 06, 2003.
Prior Publication US 2006/0257423 A1, Nov. 16, 2006
Int. Cl. A61A 39/00 (2006.01); A61K 39/29 (2006.01); A61K 38/00 (2006.01); A61K 39/04 (2006.01)

U.S. Cl. 424—184.1 [424/189.1; 424/225.1; 424/248.1; 530/350]

3 Claims

1. A HBsAg-BCG combined vaccine for intracutaneous injection, consisting of the following components (0.2 ml per vial):


	HBsAg (Hepatitis B virus surface Antigen)	5 μg~20 μg
	BCG (Bacille Calmette-Guérin)	80 μg~120 μg
	Gelatin	0.8~1.0 mg
	Saccharose	8~12 mg
	KCl	0.8~1.2 mg
	Sodium glutamate	0.8~1.2 mg
	NaCl	0.8~0.9 mg
	H₂O for injection	q.s.
	pH	6.0~7.5.